Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Pricing Zolgensma—The World’s Most Expensive Drug
by Mark Nuijten
 
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
 
Artificial Intelligence and Remote Patient Monitoring in US Healthcare Market: A Literature Review
by Ayushmaan Dubey and Anuj Tiwari
 
Implementation of Equity and Access in Indian Healthcare: Current Scenario and Way Forward
by Canna Ghia and Gautam Rambhad
 
Machine-Learning Prediction for Hospital Length of Stay Using a French Medico-Administrative Database
by Franck Jaotombo, Vanessa Pauly, Guillaume Fond, Veronica Orleans, Pascal Auquier, Badih Ghattas and Laurent Boyer
 
Impact of the COVID-19 Pandemic on the Conduct of Clinical Trials: A Quantitative Analysis
by Wojciech Margas, Piotr Wojciechowski and Mondher Toumi
 
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer and Philippe Laramée
 
EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?
by Volker Schuster
 
Burden of Illness Associated with Pneumococcal Infections in Japan—A Targeted Literature Review
by Ataru Igarashi, Maki Ueyama, Koki Idehara and Mariko Nomoto
 
The Role of Stakeholder Involvement in the Evolving EU HTA Process: Insights Generated through the European Access Academy’s Multi-Stakeholder Pre-Convention Questionnaire
by Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck, Steven Simoens, Isabelle Huys, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G.M. Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Elaine Julianadd Show full author list remove Hide full author list
Views Article
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer and Philippe Laramée
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
by Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet and Katell Le Lay
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi and Chidozie Mbada
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness
by Matthias Brunner, Manjula Schou, Robert J. Briggs and Dell Kingsford Smith
Economic Evidence on Cost Sharing and Alternative Insurance Designs to Address Moral and Behavioral Hazards in High-Income Health Care Systems: A Systematic Review
by Marlon Graf, James R. Baumgardner, Ulrich Neumann, Iris P. Brewer, Jacquelyn W. Chou and A. Mark Fendrick
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
by David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing and Neil Hawkins
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
by Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Jörg Ruofadd Show full author list remove Hide full author list
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
by Portia Lagmay-Fuentes, Andrea Smith, Shannon Krus, Laurie Lewis, Asma Latif, Tiffany Gagliardo and Manpreet Kohli
The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium
by Baudouin Standaert, Désirée Vandenberghe, Mark P. Connolly and Johan Hellings
Downloads Article
Rapid Literature Review: Definition and Methodology
by Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay and Laurent Boyer
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer and Philippe Laramée
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
by Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet and Katell Le Lay
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
by David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing and Neil Hawkins
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review
by Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi and Chidozie Mbada
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
by Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales and Jörg Ruofadd Show full author list remove Hide full author list
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy
by Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C. Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin A. Uyl-de Groot and Jörg Ruof
Assessing the Value of Delandistrogene Moxeparvovec (SRP-9001) Gene Therapy in Patients with Duchenne Muscular Dystrophy in the United States
by Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch and Daniel C. Malone
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands
by Rimma Velikanova, Sharon Wolters, Hinko S. Hofstra, Maarten J. Postma and Cornelis Boersma
EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?
by Volker Schuster
Back to TopTop